Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.

Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P

Open source

DOI: 10.1016/j.intimp.2020.106869
Published: 2020 Nov
Container: International immunopharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2020.106869,
  title = {Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.},
  author = {Dastan F and Saffaei A and Haseli S and Marjani M and Moniri A and Abtahian Z and Abedini A and Kiani A and Seifi S and Jammati H and Hashemian SMR and Pourabdollah Toutkaboni M and Eslaminejad A and Heshmatnia J and Sadeghi M and Nadji SA and Dastan A and Baghaei P and Varahram M and Yousefian S and Salamzadeh J and Tabarsi P},
  year = {2020},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2020.106869},
  url = {https://doi.org/10.1016/j.intimp.2020.106869}
}

RIS

TY  - JOUR
TI  - Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
AU  - Dastan F
AU  - Saffaei A
AU  - Haseli S
AU  - Marjani M
AU  - Moniri A
AU  - Abtahian Z
AU  - Abedini A
AU  - Kiani A
AU  - Seifi S
AU  - Jammati H
AU  - Hashemian SMR
AU  - Pourabdollah Toutkaboni M
AU  - Eslaminejad A
AU  - Heshmatnia J
AU  - Sadeghi M
AU  - Nadji SA
AU  - Dastan A
AU  - Baghaei P
AU  - Varahram M
AU  - Yousefian S
AU  - Salamzadeh J
AU  - Tabarsi P
PY  - 2020
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2020.106869
UR  - https://doi.org/10.1016/j.intimp.2020.106869
ER  -

APA

F, D., A, S., S, H., M, M., A, M., Z, A., A, A., A, K., S, S., H, J., SMR, H., M, P. T., A, E., J, H., M, S., SA, N., A, D., P, B., M, V., S, Y., J, S., & P, T. (2020). Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2020.106869

Source records

pubmed · retrieved 2026-09-27T01:22:27.515Z